Myocardial Injury as a Prognostic Factor in Mid- and Long-Term Follow-Up of COVID-19 Survivors
暂无分享,去创建一个
J. Marrugat | A. Bardají | B. Vaquerizo | C. Soler | N. Farré | N. Ribas | A. Carrasquer | Diana Mojón | Teresa Giralt | S. Pérez-Fernández | J. Carreras-Mora | Alicia Calvo-Fernández | Andrea Izquierdo | Clàudia Solà-Richarte | P. Cabero | D. Mojón
[1] Samin K. Sharma,et al. Types of myocardial injury and mid-term outcomes in patients with COVID-19. , 2021, European heart journal. Quality of care & clinical outcomes.
[2] A. Jaffe,et al. Cardiovascular biomarkers in patients with COVID-19 , 2021, European heart journal. Acute cardiovascular care.
[3] P. Kellman,et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance , 2021, European heart journal.
[4] R. Virmani,et al. Microthrombi As A Major Cause of Cardiac Injury in COVID-19: A Pathologic Study. , 2021, Circulation.
[5] A. Bardají,et al. Biomarkers and short-term prognosis in COVID-19 , 2021, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[6] Guohui Fan,et al. RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study , 2021, The Lancet.
[7] H. Reinecke,et al. Myocardial injury in severe COVID‐19 is similar to pneumonias of other origin: results from a multicentre study , 2020, ESC heart failure.
[8] J. Marrugat,et al. [Markers of myocardial injury in the prediction of short-term COVID-19 prognosis]. , 2020, Revista espanola de cardiologia.
[9] Andrew J. Layman,et al. COVID-19–Associated Nonocclusive Fibrin Microthrombi in the Heart , 2020, Circulation.
[10] Malik Peiris,et al. Virology, transmission, and pathogenesis of SARS-CoV-2 , 2020, BMJ.
[11] F. Leone,et al. Association between cardiac troponin I and mortality in patients with COVID-19 , 2020, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[12] J. Marrugat,et al. Markers of myocardial injury in the prediction of short-term COVID-19 prognosis , 2020, Revista Española de Cardiología (English Edition).
[13] Jiao Li,et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study , 2020, Clinical Microbiology and Infection.
[14] A. Bardají,et al. [Prognostic implications of myocardial injury in patients with and without COVID-19 infection treated in a university hospital]. , 2020, Revista espanola de cardiologia.
[15] Marco Merlo,et al. Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study. , 2020, JAMA cardiology.
[16] G. Condorelli,et al. Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 , 2020, Heart.
[17] Cuiyun Yuan,et al. Chest Computed Tomography and Clinical Follow-Up of Discharged Patients with COVID-19 in Wenzhou City, Zhejiang, China , 2020, Annals of the American Thoracic Society.
[18] Yanfeng Gao,et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery , 2020, EClinicalMedicine.
[19] Sharon J Peacock,et al. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. , 2020, JAMA.
[20] Angelo Carfì,et al. Persistent Symptoms in Patients After Acute COVID-19. , 2020, JAMA.
[21] Y. Adler,et al. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis? , 2020, Heart.
[22] S. Cao,et al. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019 , 2020, European heart journal.
[23] H. Shan,et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase , 2020, Respiratory Research.
[24] L. Cooper,et al. Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management , 2020, Heart Rhythm.
[25] F. Crea,et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options , 2020, Cardiovascular research.
[26] A. Amanullah,et al. Myocardial injury and COVID-19: Possible mechanisms , 2020, Life Sciences.
[27] T. West,et al. Covid-19 in Critically Ill Patients in the Seattle Region — Case Series , 2020, The New England journal of medicine.
[28] T. Strabelli,et al. COVID-19 and the Heart. , 2020, Arquivos brasileiros de cardiologia.
[29] Tao Guo,et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.
[30] W. Gong,et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. , 2020, JAMA cardiology.
[31] Xiang Xie,et al. COVID-19 and the cardiovascular system , 2020, Nature Reviews Cardiology.
[32] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[33] Ye-ming Wang,et al. Association Between Cardiac Injury and Mortality in Hospitalized Patients Infected With Avian Influenza A (H7N9) Virus , 2020, Critical care medicine.
[34] B. Long,et al. An emergency medicine approach to troponin elevation due to causes other than occlusion myocardial infarction. , 2019, The American journal of emergency medicine.
[35] Kristian Thygesen,et al. Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.
[36] W. Bos,et al. High‐sensitivity cardiac troponin T predicts mortality after hospitalization for community‐acquired pneumonia , 2017, Respirology.
[37] Patrizio Lancellotti,et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, European heart journal cardiovascular Imaging.
[38] Patrizio Lancellotti,et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[39] A. Bardají,et al. Troponina elevada en pacientes sin síndrome coronario agudo , 2015 .
[40] A. Bardají,et al. Troponin elevation in patients without acute coronary syndrome. , 2015, Revista espanola de cardiologia.
[41] Victor Mor-Avi,et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.